Lupin announced the launch of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial, to market a generic equivalent of Perforomist Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty, L.P.
Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of USD 268 million in the U.S. (IQVIA MAT September 2022).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
